Molecular insights of the G2019S substitution in LRRK2 kinase domain associated with Parkinson's disease: A molecular dynamics simulation approach

被引:30
|
作者
Agrahari, Ashish Kumar [1 ]
Doss, George Priya C. [1 ]
Siva, R. [1 ]
Magesh, R. [2 ]
Zayed, Hatem [3 ]
机构
[1] VIT, Sch Biosci & Technol, Dept Integrat Biol, Vellore 632014, Tamil Nadu, India
[2] DU, SRIHER, Dept Biotechnol, Chennai 600116, Tamil Nadu, India
[3] Qatar Univ, Coll Hlth & Sci, Dept Biomed Sci, Doha, Qatar
关键词
PD; LRRK2; Kinase domain; G2019S; DYG; Molecular dynamics simulation; MUTATIONAL ANALYSIS; PROTEIN; IMPACT; MECHANISMS; GENE; GTPASE; MODEL;
D O I
10.1016/j.jtbi.2019.03.003
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The G2019S substitution in the Leucine-rich repeat kinase 2 (LRRK2) is significantly associated with Parkinson's disease (PD). This substitution was identified in both familial and sporadic forms of PD with a higher frequency. Few computational studies have reported the impact of G2019S substitution on inhibitors of the kinase domain of LRRK2. However, no computational study deeply investigated the possible impact of the G2019S substitution on the kinase domain in its Apo conformation. Therefore, in this study, we used 200 ns molecular dynamic simulation using the GROMACS 5.1.4 package software to investigate the impact of the G2019S substitution on the structure of the kinase domain of LRRK2. Our results indicate that the G2019S substitution affects the dynamics and stability of LRRK2 by decreasing the flexibility and increasing the compactness of the kinase domain and showing its tendency to be in an active conformation for long time interval because of the high energy barrier between active and inactive conformation. This study predicts the molecular pathogenicity mechanism of the G2019S on patients with PD and provides a potential platform for developing therapeutics for patients with PD that harbor this amino acid substitution. (C) 2019 Elsevier Ltd. All rights reserved.
引用
收藏
页码:163 / 171
页数:9
相关论文
共 50 条
  • [1] LRRK2 G2019S Mutations are Associated with an Increased Cancer Risk in Parkinson Disease
    Saunders-Pullman, Rachel
    Barrett, Matthew J.
    Stanley, Kaili M.
    San Luciano, Marta
    Shanker, Vicki
    Severt, Lawrence
    Hunt, Ann
    Raymond, Deborah
    Ozelius, Laurie J.
    Bressman, Susan B.
    MOVEMENT DISORDERS, 2010, 25 (15) : 2536 - 2541
  • [2] Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease
    Alcalay, Roy N.
    Mejia-Santana, Helen
    Mirelman, Anat
    Saunders-Pullman, Rachel
    Raymond, Deborah
    Palmese, Christina
    Caccappolo, Elise
    Ozelius, Laurie
    Orr-Urtreger, Avi
    Clark, Lorraine
    Giladi, Nir
    Bressman, Susan
    Marder, Karen
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (02) : 106 - 110
  • [3] Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity
    An Phu Tran Nguyen
    Tsika, Elpida
    Kelly, Kaela
    Levine, Nathan
    Chen, Xi
    West, Andrew B.
    Boularand, Sylviane
    Barneoud, Pascal
    Moore, Darren J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (29) : 17296 - 17307
  • [4] The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation
    Hassin-Baer, Sharon
    Laitman, Yael
    Azizi, Esther
    Molchadski, Irena
    Galore-Haskel, Gilli
    Barak, Frida
    Cohen, Oren S.
    Friedman, Eitan
    JOURNAL OF NEUROLOGY, 2009, 256 (03) : 483 - 487
  • [5] Frequency of the LRRK2 G2019S mutation in South African patients with Parkinson's disease
    du Toit, Nicola
    van Coller, Riaan
    Anderson, David G.
    Carr, Jonathan
    Bardien, Soraya
    NEUROGENETICS, 2019, 20 (04) : 215 - 218
  • [6] Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: A systematic review
    Guedes, L. Correia
    Ferreira, J. J.
    Rosa, M. M.
    Coelho, M.
    Bonifati, V.
    Sampaio, C.
    PARKINSONISM & RELATED DISORDERS, 2010, 16 (04) : 237 - 242
  • [7] Frequency of the LRRK2 G2019S mutation in South African patients with Parkinson’s disease
    Nicola du Toit
    Riaan van Coller
    David G. Anderson
    Jonathan Carr
    Soraya Bardien
    neurogenetics, 2019, 20 : 215 - 218
  • [8] LRRK2 G2019S Mutation: Prevalence and Clinical Features in Moroccans with Parkinson's Disease
    Bouhouche, Ahmed
    Tibar, Houyam
    Ben El Haj, Rafiqua
    El Bayad, Khalil
    Razine, Rachid
    Tazrout, Sanaa
    Skalli, Asmae
    Bouslam, Naima
    Elouardi, Loubna
    Benomar, Ali
    Yahyaoui, Mohammed
    Regragui, Wafa
    PARKINSONS DISEASE, 2017, 2017
  • [9] Frequency of the LRRK2 G2019S mutation in Italian patients affected by Parkinson's disease
    Squillaro, Tiziana
    Cambi, Franca
    Ciacci, Giuseppe
    Rossi, Simone
    Ulivelli, Monica
    Malandrini, Alessandro
    Mencarelli, Maria Antonietta
    Mari, Francesca
    Renieri, Alessandra
    Ariani, Francesca
    JOURNAL OF HUMAN GENETICS, 2007, 52 (03) : 201 - 204
  • [10] LRRK2 G2019S mutation does not contribute to Parkinson's disease in South India
    Vijayan, Bejoy
    Gopala, Srinivas
    Kishore, Asha
    NEUROLOGY INDIA, 2011, 59 (02) : 157 - 160